Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - Two-year maintenance therapy with olaparib, a PARP (poly ADP ribose polymerase) inhibitor,...
Credit: Phil Jones, Senior Photographer, Augusta University AUGUSTA, Ga. (Oct. 22, 2018) - Biofeedback therapy used at home is about 70 percent effective at helping...
A new study reveals that Hispanic HIV-infected adults in the United States are at a higher risk of developing cancers caused by the human papillomavirus...
Credit: Osaka University Osaka, Japan -- Over 1 billion years ago, a relationship began between the ancestor of all living plants and a type of...
ESMO 2018 abstract LBA21 - "InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP) plus 5-fluorouracil (5-FU) vs carboplatin...
Credit: Dong-Ha Bhang, Penn Medicine: Nature Communications PHILADELPHIA - Researchers have discovered a way to grow human stem cells destined to become mature sperm in...
Biological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targeted drugs and vaccines - but they are also...
Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - A high concentration of multi-strain probiotic helps to reduce mild to moderate...
Munich, Germany, 20 October 2018 - Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the aromatase inhibitor letrozole significantly increases...
Credit: © European Society for Medical Oncology Munich, Germany, 20 October 2018 - Epigenetic therapy with histone deacetylase (HDAC) inhibitors is worth pursuing in hormone...
(European Society for Medical Oncology) Targeting a common mutation in patients with hormone receptor positive (HR+) HER2 negative (HER2-) advanced breast cancer with the alpha-specific...
Credit: Duke-NUS Medical School Singapore, 22 October 2018 - Global efforts in immuno-oncology have received a major boost, with a S$22 million Health and Biomedical...
Credit: © European Society for Medical Oncology Munich, Germany, 22 October 2018 - Immunotherapy with nivolumab and low-dose ipilimumab could become a new first line...
Credit: © European Society for Medical Oncology Munich, Germany, 22 October 2018 - Pre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and...
PHILADELPHIA - A new program project grant from the National Cancer Institute (NCI) will fund research by the Translational Center of Excellence for Lung Cancer...
